• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类α1-蛋白酶抑制剂不同形式的免疫鉴别

Immunological discrimination of diverse forms of human alpha 1-proteinase inhibitor.

作者信息

Wawrzos I, Kitagawa Y, Kołoczek H

机构信息

Agriculture University, Department of Biochemistry, Cracow, Poland.

出版信息

Acta Biochim Pol. 1996;43(3):481-7.

PMID:8922030
Abstract

The immunodiffusion cross-reactivity and competitive inhibition ELISA assays were used for immunological differentiation of latent form, cleaved form and guanidinium hydrochloride (GuHCl) induced polymer of human alpha 1-proteinase inhibitor (alpha 1-PI). Under the conditions studied, the differences between latent form and GuHCl-induced polymers of the inhibitor in terms of immunological response were estimated to amount to about 30% and differences between latent and cleaved alpha 1-PI to about 50%. The immunodiffusion and ELISA data for citrate-induced polymers suggest that in their structure the latent molecule is involved. On the basis of competitive inhibition data, we suggest that the alpha 1-PI protein polymerisation involves insertion of the reactive-site loop (RSL) into the A-sheet under mild conditions and that in the latent form of the inhibitor RSL is incompletely inserted into the A-sheet.

摘要

免疫扩散交叉反应和竞争性抑制酶联免疫吸附测定法被用于对人α1-蛋白酶抑制剂(α1-PI)的潜伏形式、裂解形式以及盐酸胍(GuHCl)诱导的聚合物进行免疫分化。在所研究的条件下,抑制剂的潜伏形式与GuHCl诱导的聚合物在免疫反应方面的差异估计约为30%,而潜伏型和裂解型α1-PI之间的差异约为50%。柠檬酸盐诱导聚合物的免疫扩散和酶联免疫吸附测定数据表明,潜伏分子参与了其结构。基于竞争性抑制数据,我们认为α1-PI蛋白聚合涉及在温和条件下反应位点环(RSL)插入A片层,并且在抑制剂的潜伏形式中,RSL未完全插入A片层。

相似文献

1
Immunological discrimination of diverse forms of human alpha 1-proteinase inhibitor.人类α1-蛋白酶抑制剂不同形式的免疫鉴别
Acta Biochim Pol. 1996;43(3):481-7.
2
Computer modelling of human alpha 1-antitrypsin reactive site loop behaviour under mild conditions.轻度条件下人类α1-抗胰蛋白酶反应位点环行为的计算机模拟
Acta Biochim Pol. 1996;43(3):467-74.
3
Differential effects of heparin and glucose on structural conformation of human alpha1 antitrypsin: evidence for a heparin-induced cleaved form of the inhibitor.肝素和葡萄糖对人α1抗胰蛋白酶结构构象的不同影响:肝素诱导抑制剂裂解形式的证据。
Arch Biochem Biophys. 1997 Nov 1;347(1):19-29. doi: 10.1006/abbi.1997.0317.
4
Determination of alpha1-proteinase inhibitor by a new enzyme linked immunosorbant assay in feces, serum and an enterocyte-like cell line.采用一种新的酶联免疫吸附测定法测定粪便、血清及一种肠上皮样细胞系中的α1-蛋白酶抑制剂。
Z Gastroenterol. 2001 Sep;39(9):769-74. doi: 10.1055/s-2001-17194.
5
Development and evaluation of an ELISA for quantification of human alpha-1-proteinase inhibitor in complex biological mixtures.用于定量复杂生物混合物中人α1-蛋白酶抑制剂的酶联免疫吸附测定法的开发与评估
Biologicals. 2007 Oct;35(4):285-95. doi: 10.1016/j.biologicals.2006.11.002. Epub 2007 Jan 24.
6
[Comparative immunochemical studies of human and animal beta-lipoprotein, alpha 2-macroglobulin and alpha 1-antitrypsin by ELISA methods--forensic immunological studies on human specificity, report-XXI].[采用酶联免疫吸附测定法对人和动物β-脂蛋白、α2-巨球蛋白及α1-抗胰蛋白酶进行的比较免疫化学研究——关于人类特异性的法医免疫学研究,报告二十一]
Nihon Hoigaku Zasshi. 1987 Aug;41(4):351-7.
7
Wild-type alpha 1-antitrypsin is in the canonical inhibitory conformation.野生型α1-抗胰蛋白酶处于典型的抑制构象。
J Mol Biol. 1998 Jan 23;275(3):419-25. doi: 10.1006/jmbi.1997.1458.
8
Cleaved antitrypsin polymers at atomic resolution.原子分辨率下的裂解抗胰蛋白酶聚合物
Protein Sci. 2000 Feb;9(2):417-20. doi: 10.1110/ps.9.2.417.
9
Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.L-抗凝血酶的制备性诱导与表征:潜在纤溶酶原激活物抑制剂-1的结构同源物
Biochemistry. 1997 Oct 21;36(42):13133-42. doi: 10.1021/bi970664u.
10
Dimers initiate and propagate serine protease inhibitor polymerisation.二聚体引发并促进丝氨酸蛋白酶抑制剂的聚合反应。
J Mol Biol. 2008 Jan 4;375(1):36-42. doi: 10.1016/j.jmb.2007.10.055. Epub 2007 Oct 25.